Search

Displaying results 6011 - 6020 of 10000 in total
  1. Drug

    Evernia prunastri

    go.drugbank.com/drugs/DB14172
    Approved

    Evernia prunastri allergenic extract is used in allergenic testing.

  2. Drug

    Beef liver

    go.drugbank.com/drugs/DB14694
    Approved

    Beef liver allergenic extract is used in allergenic testing.

  3. Drug

    Camponotus pennsylvanicus

    go.drugbank.com/drugs/DB14710
    Approved

    Camponotus pennsylvanicus allergenic extract is used in allergenic testing.

  4. Drug

    Eurotium amstelodami

    go.drugbank.com/drugs/DB15526
    Approved

    Eurotium amstelodami allergenic extract is used in allergenic testing.

  5. Drug

    Skim milk

    go.drugbank.com/drugs/DB15546
    Approved

    Skim milk allergenic extract is used in allergenic testing.

    Synonyms: Lac defloratum
  6. Drug

    Field mushroom

    go.drugbank.com/drugs/DB15605
    Approved

    Field mushroom allergenic extract is used in allergenic testing.

  7. Drug

    Levcromakalim

    go.drugbank.com/drugs/DB21154
    Investigational

    Levcromakalim is a small molecule drug. The usage of the INN stem '-kalim' in the name indicates that Levcromakalim is a potassium channel activator, antihypertensive. … Levcromakalim is under investigation in clinical trial NCT04853797 (Effect of Ivabradine on Levcromakalim-Induced Symptoms in Individuals With Migraine Without Aura (ILIM)).

  8. Drug

    Avexitide

    go.drugbank.com/drugs/DB14806
    ApprovedInvestigationalWithdrawn

    Avexitide is under investigation in clinical trial NCT02996812 (Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia).

  9. Drug

    Agrostis gigantea top

    go.drugbank.com/drugs/DB14757
    ApprovedWithdrawn

    Agrostis gigantea top is the flowering part of the Agrostis gigantea plant. Agrostis gigantea top is mainly used in allergenic testing.

    Products: Center-AL - Agrostis Gigantea
  10. Drug

    Upanovimab

    go.drugbank.com/drugs/DB16505
    Investigational

    Upanovimab (SCTA01) was under investigation in clinical trials (NCT04683328, NCT04644185, NCT04709328 and NCT05156645) to evaluate its safety and efficacy in patients with severe COVID-19